Skip to content

G&A at other companies

eXoZymes Inc. Common Stock logo
eXoZymes Inc. Common StockEXOZ
$1.27M-8.0%
NuSkin Enterprises logo
NuSkin EnterprisesNUS
$98.54M-13.0%
John B. Sanfilippo & Son logo
John B. Sanfilippo & SonJBSS
$10.72M+18.3%

Segments

By segment

See full
Analytical Reference Standards and Services segment$0
Consumer Products segment$0
Ingredients segment$0
Pharmaceuticals segment$0

Other financials

Income statement

See full
Revenue$31.5M+3.3%
Gross profit$20.0M+3.3%
Operating income$1.6M-67.0%
Net income$6.3M+24.8%
EPS (diluted)$0.07+16.7%

Balance sheet

See full
Cash & equivalents$66.5M+19.7%
Total debt$2.6M-26.9%
Total equity$82.3M+48.8%
Total assets$114.3M+40.6%

Cash flow

See full
Operating cash flow-$1.2M-115%

Valuation

See full
Market cap$254.07M-74.9%
Enterprise value$190.09M-79.7%
P/E13.6×-43.5×
P/S-6.8×

Profitability

See full
Gross margin64.3%+1.8pp
Operating margin10%-2.2pp
Net margin14.3%+1.2pp
FCF margin-70.4%

Returns & leverage

See full
Return on equity27.1%-6.4pp
Debt / equity0.0×
Current ratio4.6×+0.9×

Where this comes from

Reported directly by NAGE in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NAGE's G&A?
NAGE (NAGE) reported G&A of $7.24M in Q1 2026.
How has NAGE's G&A changed year-over-year?
NAGE's G&A increased by 39.7% year-over-year, from $5.18M to $7.24M.
What is the long-term trend for NAGE's G&A?
Over 3 years (2021 to 2025), NAGE's G&A has grown at a -9.4% compound annual growth rate (CAGR), from $36.38M to $27.06M.
What does G&A mean?
Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.